Skip to search formSkip to main contentSkip to account menu

gadobutrol

Known as: (10-((1RS,2SR)-2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium, gadobutrol [Chemical/Ingredient], gadolinium(III) 2,2',2''-(10-((2R,3S )-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
A gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI). Gadobutrol is a non-ionic… 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Contrast MediaOrganometallic Compounds
GADOBUTROL 604.72 mg in 1 mL INTRAVENOUS INJECTION [Gadavist]Gadolinium-based Contrast Agent [EPC]

Narrower (1)

Gadovist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
T1 Shortening in the Globus Pallidus after Multiple Administrations of Gadobutrol: Assessment with a Multidynamic Multiecho Sequence.
Purpose To determine the association between the administration of the macrocyclic contrast medium gadobutrol and T1 relaxation… 
2011
2011
MRI performed after intratympanic gadolinium administration in patients with Ménière’s disease: correlation with symptoms and signs
The objective of the study was to compare the outcomes of a series of diagnostic parameters in Ménière’s disease (MD) patients… 
Review
2010
Review
2010
Gadobutrol-enhanced, Three-Dimensional, Dynamic MR Imaging With MR Cholangiography for the Preoperative Evaluation of Bile Duct Cancer
Purpose:To evaluate the diagnostic performance of 1.0-M gadobutrol-enhanced, 3-dimensional (3D), dynamic MR images with 3D-MR… 
2009
2009
Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver Lesions: Results of a…
Objective:To evaluate the diagnostic efficacy (accuracy, sensitivity, specificity) of 1.0 M gadobutrol versus 0.5 M gadopentetate… 
2008
2008
Comparison of different contrast agents and doses for quantitative MR myocardial perfusion imaging
To investigate three different contrast agents at different injection volumes for repetitive quantitative multislice myocardial… 
2004
2004
In Vivo Measurement of Gadolinium Concentration in a Rat Glioma Model by Monochromatic Quantitative Computed Tomography: Comparison Between Gadopentetate Dimeglumine and Gadobutrol
Rationale and Objectives:Monochromatic quantitative computed tomography allows a nondestructive and quantitative measurement of… 
Highly Cited
2003
Highly Cited
2003
Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experience
To determine whether higher concentrated gadolinium chelates are advantageous for the recently introduced concept of total‐body… 
1997
1997
Sicherheit und Nutzen von Gadobutrol bei Patienten mit zerebralen Tumoren (Phase-III-Studie)
Ziel: Methodik: Ergebnisse: Schlußfolgerung: Purpose: Methods: Results: Conclusion: 
1995
1995
Evaluation of Gadobutrol in a Rabbit Model as a New Lanthanide Contrast Agent for Computed Tomography
RATIONALE AND OBJECTIVES.The efficacy of the neutral lanthanide contrast agent gadobutrol was compared to that of the iodinated… 
Highly Cited
1994
Highly Cited
1994
Dynamic contrast‐enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium‐DTPA‐polylysine, and gadolinium‐DTPA‐cascade‐polymer
The enhancement properties of gadobutrol (40 and 80 μmol/kg body weight, 550 daltons), gadolinium‐DTPA‐polylysine (20 μmol/kg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)